SINGAPORE,Feb. 18,2025-- Thailand is enjoying the global spotlight following the season premiere of the popular HBO show \'The White Lotus\'. For the island of Koh Samui in particular,the series\' ma
READ MORELOS ANGELES,Feb. 18,2025-- Waterdrop Filter,a leading innovator in water filtration solutions,is set to showcase its diverse range of water purification products at the upcoming Kitchen & Bath In
SHENZHEN,China,Feb. 18,2025--TencentMusic Entertainment Group ("TME",or the "Company") (NYSE: TME and HKEX: 1698),the leading online music and audio entertainment platform inChina,
SHANGHAI,Jan. 16,2025-- A news report from english.shanghai.gov.cn Shanghai announced on Jan 8 plans to encourage the establishment of wholly foreign-owned hospitals in the municipality\'s key economi
SAN FRANCISCO andSUZHOU,China,Jan. 16,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
FORNEBU,Norway,Jan. 16,2025-- Reference is made to the announcement byAker Horizons ASA ("Aker Horizons" or the "Company") on 9 January 2025 regarding fixed income investor meeting
SYDNEY,Jan. 16,2025-- The stage is set for one of Australia\'s most prestigious celebrations of small business excellence!
NUC Found Guilty of Patent Infringement,Ordered to Cease Activities,Pay Fines SEOUL,South Korea,Jan. 16,2025-- Hurom,the pioneer of low-speed masticating juicers and a global market leader,has succes
SINGAPORE,Jan. 15,2025--ShengShu Technology,a pioneer in generative video,is introducing a game-changing Vidu 2.0 update for its flagship video generation application Vidu. With 10 million users in ju
PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa
JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the
SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch
For its third edition,the annual entrepreneurship programme aims to drive change by identifying and supporting women social impact entrepreneurs from South Asia.
© OfficialAffairs
